KRISTINE M BALL
CIK 1266163 · See Remarks · last filed 2026-06-03
KRISTINE M BALL is a corporate insider who has filed 26 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for ORKA, was dated Jun 3, 2026. Across all open-market trades the lifetime net is −$198.5K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
26
-$198.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ORKA | Director | — | $69.89 | — | $0 | 2 | 2026-06-03 |
| Atreca, Inc. (BCEL) Delisted | Director | — | $0.15 | — | $0 | 5 | 2023-06-15 |
| Forty Seven, Inc. (FTSV) Delisted | Director | — | — | — | $0 | 2 | 2020-04-07 |
| VYNE Therapeutics Inc. (MNLO) Delisted | See Remarks | 80,300 | — | — | $0 | 6 | 2019-12-16 |
| Relypsa Inc (RLYP) Delisted | Chief Financial Officer & SVP | 0 | — | — | -$198.5K | 11 | 2016-09-02 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | ORKA | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | ORKA | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-11 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-15 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-21 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-04-07 | Forty Seven, Inc. (FTSV) Delisted | Disp (D) | — | $0 | EDGAR |
| 2019-12-16 | VYNE Therapeutics Inc. (MNLO) Delisted | Mixed | +52,534 | -$125.5K | EDGAR |
| 2019-12-13 | VYNE Therapeutics Inc. (MNLO) Delisted | Mixed | +52,534 | -$125.5K | EDGAR |